Can't see this email? View it as a web page here.
Hanover Research- Health Grant Alerts

For the next several weeks, our regular Grant Alerts update emails will lead off with a comprehensive overview of the funding landscape pertaining to the COVID-19 response effort.

Hanover Research is closely monitoring developments surrounding the Coronavirus Disease 2019 (COVID-19) and how it has and may continue to impact the higher education and health research communities. This resource center (PDF version here) provides key facts, resources, and potential responses to this rapidly evolving situation. Our team has also created a new visualization dashboard of CARES Act funding by agency and award type. Our dedicated COVID-19 support email ( is ready to answer any questions related to COVID-19. In addition, and as always, your dedicated Content Director and Relationship Director also are ready to help with custom research solutions to the challenges you are facing.


CARES Act Funding Updates

Department of Education

As noted in our previous update, the Department of Education has issued various guidance pertaining to CARES Act grant distribution. For IHEs, CARES Act funds are received by filling out an institutional certification form. If you have not yet received your Opportunity Number from the Department of Education, this should be forthcoming shortly from ED’s Higher Education Programs division. See the following resources for more details:

Other CARES Act News


General COVID-19 Funding Updates

In addition to CARES Act funding, listed above, these new COVID-19 grant opportunities may be of interest:

  • AHRQ has announced a forecasted opportunity, with a deadline likely to fall in early-to-mid-summer, to support novel, high-impact studies evaluating health system and healthcare professional responsiveness to COVID-19. Exact funding amounts and further details will be announced in the coming weeks.
  • The Microsoft AI for Health COVID-19 program is now accepting requests for grants from nonprofits, academia, and governments. This program provides Azure cloud and High-Performance Computing capabilities. Microsoft's team of AI for Health data science experts, whose mission is to improve the health of people and communities worldwide, is also open to collaborations with COVID-19 researchers as they tackle this critical challenge. More broadly, Microsoft’s research scientists across the world, spanning computer science, biology, medicine, and public health, will also be available to provide advice and collaborate per mutual interest. Proposals are due by June 15, 2020.
  • The Moore Foundation's goal is to strengthen accountability for diagnostic excellence by helping to develop and validate new measures for diagnostic performance, working to both minimize barriers for innovation and advocate for the safe and responsible deployment of these technologies in the clinical category of infections (apparently including COVID-19). Grants are up to $500,000. Proposals are due by June 30, 2020.
  • The Harrington Scholar Award for Coronavirus call for proposals is part of a recently announced major initiative to support the global fight against COVID-19 and potential future pandemic events. The Harrington Discovery Institute will provide successful applicants with grant funding and expert guidance and oversight in all aspects of drug/therapeutics development, while taking no rights to intellectual property, which is retained by the award recipient and their institution. Grants range from $150,000 to $1 million. Full proposals are due by April 30, 2020.

Previously Announced COVID-19 Funding Opportunities

The funding opportunities listed in the table below were profiled in our previous COVID-19 updates and remain viable to approach (sorted by deadline):





Private Funder

North Carolina Biotechnology Center Flash Grant

Seeks small-scale proposals pertaining to COVID-19 vaccine development, diagnosis, and specific therapies.

April 22, 2020

NIH NOSIs Notices of Special Interest

Many NIH ICs have announced supplemental and/or emergency research funding (condensed here in the interests of space): NCATS therapeutics, NCATS R21, NIMH Mentoring Networks, NIA/NIAAA/NIMHD/NIMH mental health research, NIMHD/NIA/NIMH minority health research, NCCIH/NIA/NIAAA stress-related research, NIAID counter-measures, and general announcements from the NCI, NIDCD, NIDDK, NLM, NIEHS, NIAID, NHGRI, NHLBINIBIB, NIA/NIMH/NIAAANIGMS, NCATS, and NIDCR.

Varies by IC (from April 2020 to late 2021)

DOD Air Force

Small Business Innovation Research (SBIR) Program

University researchers may serve as subcontractors for any small business’ commercializable R&D pertaining to AF-related COVID-19 topics.

April 30, 2020

Private Funder

CoVent-19 Challenge

Open innovation eight-week Grand Challenge for engineers, innovators, designers, and makers to create respirator models.

May 1, 2020 (first round)

Private Funder

AI Techniques to Mitigate Pandemic

Microsoft,, and various universities have announced an RFP for using data analytics and AI methods to research COVID-19.

May 1, 2020


Newton Award for Transformative Ideas during the COVID-19 Pandemic

Funds “transformative ideas” to resolve challenges, advance frontiers, and set new paradigms in areas of immense potential benefit to DoD, including COVID-19 research. 

May 15, 2020

DOD Army

National Emergency Telecritical Care Network (NETCCN) Project for Coronavirus

A pre-announcement for proposals to rapidly develop and deploy the National Emergency Telecritical Care Network: a cloud-based, low-resource, stand-alone health information management system.

Projected mid-May 2020

Private Funder

Russell Sage Foundation COVID-19 Research

RSF is accepting LOIs for research that analyzes social, political, economic, or psychological disruptions resulting from COVID-19.

May 21, 2020 (LOI)


CDMRP Emerging Viral Diseases and Respiratory Health

Three tracks for (1) clinical trials, (2) investigator-initiated research, and (3) technology/therapeutic development have been announced.

May 28 or June 8, 2020 (pre-application)

Private Funder

Pfizer Enhanced Medical Support for Patients with Primary Immunodeficiency Disorders

Supports projects that leverage the utilization of innovative technology platforms for distant learning to reach the intended audience with a focus on patient outreach, medical support and telework. (Pfizer is also offering smaller-scale programs for niche medical areas; see here.)

June 8, 2020 

Private Funder

MIT Solve

Seeks innovations that can slow and track the spread of an emerging outbreak, for example by improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making, and providing tools that support and protect health workers. 

June 18, 2020

DOD Army

Prototype Development to Combat COVID-19

A potential request for project proposals for technologies such as point-of-care testing, therapeutics, and patient tracking systems.

Projected mid-2020

German Gov't

DFG Call for Multidisciplinary Research into Epidemics and Pandemics in Response to the Outbreak of SARS-CoV-2

Encourages international partnerships for projects addressing prevention, early detection, containment, and investigation of the causes, impacts, and management of pandemics.

July 1, 2020 (LOI)


Distance Learning and Telemedicine Grant Program

The DLT program has added a new deadline using existing funding as well as the $25 million in additional CARES Act funding. 

July 13, 2020 

Private Funder

Merck KGaA Research Grants 

Aims to stimulate innovative research in challenging areas of future importance, including pandemic preparedness and fighting new emerging viral infectious diseases.

August 31, 2020


Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

Seeks research for an array of medical countermeasures to diagnose, treat, or protect against against COVID-19.

October 31, 2020


Dear Colleague Letter on COVID-19

Encourages research community to respond through existing NSF opportunities via the RAPID funding mechanism for COVID-19 topics.

Varies by NSF program


Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on COVID-19

Invites RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities.

Varies by NSF program


Biomedical Advanced Research and Development Authority (BARDA) Novel Coronavirus EZ-BAA

Seeks research for molecular diagnostic assays, point-of-care detection, screening models, and other topics pertaining to COVID-19.



Request for SBIR/STTR Phase I Proposals Addressing COVID-19

University researchers may serve as subcontractors for any small business’ commercializable R&D pertaining to NSF-related COVID-19 topics.

Rolling (quarterly)


R01, R21, SBIR/STTR for COVID-19

Three of the largest NIH parent/umbrella funding mechanisms have now been updated to indicate that applications pertaining to COVID-19 research are welcomed.

Standard dates (rolling / tri-annual) for R01, R21, SBIR/STTR


Dear Colleague Letter

Encourages scientific questions that underpin COVID-19 response that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure.


Private Funder

Google Cloud Research Credits

A total of $20 million in Google Cloud research credits will be provided for leveraging Google’s computing capabilities and infrastructure to study therapies, vaccines, etc.


Private Funder

Amazon AWS Diagnostic Development Initiative

Amazon has announced $20 million to provide technical support and AWS promotional credits for existing AWS customers to advance diagnostic research.


Private Funder

Fast Funding for COVID-19 Science

Funds projects that will help with the COVID-19 pandemic within the next six months. Grants are up to $500,000, and decisions are made in under 48 hours.



COVID-19 Resources and Guidance

Resource Hubs:

National Science Foundation Updates:

Department of Health and Human Services Updates:

Other Federal Updates:

Private/Foundation Resources and Updates:

* * *

Below is a recap of research funding opportunities that were recently announced, nationwide. While these alerts are intended to provide you with a broad-reaching overview of the opportunities available, we certainly want to hear if there are specific opportunities that you would like to pursue. Please let your Content Director know if you have any questions or are interested in learning more. It should also be kept in mind that some grant-makers may shift their priorities to better address the public health impacts of the pandemic. It will be important to continually monitor funding announcement deadlines as grant-makers pivot to meet the changing demands of society.

Grant Name: Clinical Trials in Organ Transplantation in Children and Adults (U01 Clinical Trial Optional) (NIH)
Summary:  The purpose of this FOA is to solicit applications to participate in a clinical studies program to improve the long-term outcome of adult and pediatric transplant recipients (thoracic organ, abdominal organ, vascular composite tissue, and cellular replacement).
Eligibility:  There are no eligibility restrictions.
Dates: LOIs are due by September 9, 2020; full proposals by October 9, 2020.
Grant Name: National Centers for Biomedical Imaging and Bioengineering (P41 Clinical Trials Optional) (NIH)
Summary:  This Funding Opportunity Announcement encourages grant applications for National Centers for Biomedical Imaging and Bioengineering. NCBIB are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. NCBIB also make their technologies available to other investigators, train members of the research community in the use of the technologies and disseminate the technologies broadly.
Eligibility:  There are no eligibility restrictions.
Dates: LOIs are due 12 weeks before standard tri-annual NIH dates.
Grant Name: Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (R01 Clinical Trials Not Allowed) (NIH)
Summary:  This Funding Opportunity Announcement encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology and manifestations of myalgic encephalomyelitis/chronic fatigue syndrome in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among individuals with ME/CFS, and the common mechanisms influencing the multiple affected body systems in ME/CFS are encouraged. There is also an R21 track.
Eligibility:  There are no eligibility restrictions.
Dates: Standard tri-annual NIH dates apply.
Grant Name: Addressing Racial Disparities in Maternal Mortality and Morbidity (R01 Clinical Trial Optional) (NIH)
Summary:  This initiative will support multidisciplinary research examining mechanisms underlying racial and ethnic disparities in maternal mortality and morbidity, testing the efficacy and/or effectiveness of multi-level interventions, and/or research strategies to optimally and sustainably deliver proven-effective prevention and treatment interventions to reduce these disparities.
Eligibility:  There are no eligibility restrictions.
Dates: LOIs are due by April 29, 2020; full proposals by May 29, 2020.
Grant Name: Improving Care and Treatment Coordination: Focusing on Black Women with HIV – Demonstration Sites (HRSA)
Summary:  This notice announces the opportunity to apply for fiscal year 2020 funding under the Improving Care and Treatment Coordination: Focusing on Black Women with HIV – Demonstration Sites. Funding awarded under this announcement will support up to seven cooperative agreements for up to three years to design, implement, and conduct research to evaluate the use of bundled interventions for Black women with HIV. Bundled interventions are a group of evidence-informed practices put together into a package that when implemented together produces better health outcomes than when the practices are delivered separately.
Eligibility:  There are no eligibility restrictions.
Dates: Proposals are due by June 15, 2020.

Grant Name: Cystic Fibrosis Foundation Invites Applications for Pilot and Feasibility Awards
Summary:  The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and provide all people with CF the opportunity to lead long, fulfilling lives. To advance this mission, the foundation is inviting applications for its Pilot and Feasibility Awards program. Through the program, grants of up to $50,000 per year for up to two years will be awarded in support of basic research studies focused on developing and testing new hypotheses in areas relevant to cystic fibrosis. Information derived from such studies must have the potential to lead to submission to other funding agencies such as the National Institutes of Health. Proposed work must be hypothesis-driven and must reflect innovative approaches to critical questions in CF research.
Eligibility:  There are no eligibility restrictions.
Dates:  Proposals are due by May 13, 2020.
Grant Name: Gerber Foundation Invites Applications for Pediatric Research
Summary:  The Gerber Foundation is dedicated to enhancing the quality of life of infants and young children, with an emphasis on children under three years of age. To that end, the foundation is accepting applications for research projects aimed at identifying solutions to common everyday issues and problems in the field of children’s health and nutrition. Of particular interest to the foundation are projects offering substantial promise of meaningful advances in prevention and treatment of disease and those with broad and general applicability.
Eligibility:  There are no eligibility restrictions.
Dates:  Concept papers are due by May 15, 2020.
Grant Name: One Mind Invites Applications for Neuropsychiatric Research Awards
Summary:  One Mind is inviting applications for its Rising Star Research Awards program, which seeks to fund early-career investigators who have demonstrated productivity and innovation in a scientific field that can be applied to the study of neuropsychiatric disorders such as anxiety, addiction, bipolar disorder, depression, posttraumatic stress, schizophrenia, traumatic brain injury, suicidality, and other serious psychiatric illnesses. To that end, grants of $300,000 over three years will be awarded in support of research proposals on any of a wide range of neuropsychiatric conditions.
Eligibility:  There are no eligibility restrictions.
Dates:  Proposals are due by May 13, 2020.


We'll be happy to help you find the right grants opportunity for your organization.
  Twitter   LinkedIn  

About Hanover Research: Founded in 2003, Hanover Research is a global research and analytics firm that delivers market intelligence through a unique, fixed-fee model to more than 1,000 clients. Headquartered in Arlington, Virginia, Hanover employs high-caliber market researchers, analysts, and account executives to provide a service that is revolutionary in its combination of flexibility and affordability. Hanover was named a Top 50 Market Research Firm by the American Marketing Association in 2015, 2016, and 2017, and has also been twice named a Washington Business Journal Fastest Growing Company. To learn more about Hanover Research, visit